跳至主要内容
临床试验/NCT01555190
NCT01555190已完成不适用

Combination Therapy With Myo-inositol and Folic Acid Versus Myo-inositol Alone: Effects of Six Months Treatment on Clinical, Endocrine and Metabolic Features in Obese Women With Polycystic Ovary Syndrome

Catholic University of the Sacred Heart1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2012年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
number of cycles in six months of therapy

研究概览

简要总结

Previous studies have demonstrated that Myo-inositol is capable of restoring spontaneous ovarian activity, and consequently fertility, in most patients with PCOS. The aim of our study is to investigate the role of folic acid conteined in the inositol preparation. The study group included 50 patients, randomly allocated to subgroup A (myo-inositol 1500 gr) and subgroup B (myo-inositol 2000 gr + folic acid 200 mcg). The investigation include menstrual pattern and hirsutism score evaluation, hormonal assays, oral glucose tolerance test, euglycemic hyperinsulinaemic clamp and lipide profile at baseline and after six months of treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • women with PCOS diagnosed in accordance with Rotterdam Consensus Conference Criteria 2003
  • BMI > 25 kg/m2
  • age 18-35 years

排除标准

  • pregnancy
  • significant liver or renal impairment
  • other hormonal dysfunctions (hypothalamic, pituitary, thyroidal or adrenal causes for the clinical signs)
  • neoplasms
  • unstable mental illness
  • diagnosis of diabetes mellitus or impaired glucose tolerance
  • use of drugs able to interfere with gluco-insulinaemic metabolism for at least three months prior entering the study.

研究组 & 干预措施

myo-inositol 1500 gr

Active Comparator

6 months treatment with myo-inositol 1500 gr

干预措施: myo-inositol 1500 gr (Drug)

myo-inositol 2000gr + folic acid 200 mcg

Active Comparator

干预措施: myo-inositol 2000 gr + folic acid 200 mcg (Drug)

结局指标

主要结局

number of cycles in six months of therapy

时间窗: 6 months

We'll estimate the efficacy of the two treatments on the ovarian function and menstrual pattern.

次要结局

  • effects oon lipide profile(6 months)
  • effects on oral glucose tollerance test(six months)
  • effects on hoormonal assay(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Maurizio Guido

medical doctor

Catholic University of the Sacred Heart

研究点 (1)

Loading locations...

相似试验